These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8488569)

  • 1. The Cheng-Prusoff relationship: something lost in the translation.
    Craig DA
    Trends Pharmacol Sci; 1993 Mar; 14(3):89-91. PubMed ID: 8488569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further concerns over Cheng-Prusoff analysis.
    Leff P; Dougall IG
    Trends Pharmacol Sci; 1993 Apr; 14(4):110-2. PubMed ID: 8516953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations.
    Cheng HC
    J Pharmacol Toxicol Methods; 2001; 46(2):61-71. PubMed ID: 12481843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation.
    Lazareno S; Birdsall NJ
    Trends Pharmacol Sci; 1993 Jun; 14(6):237-9. PubMed ID: 8372404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations.
    Lazareno S; Birdsall NJ
    Br J Pharmacol; 1993 Aug; 109(4):1110-9. PubMed ID: 8401922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of competitive antagonist affinity by the Schild method and from functional inhibition curves using a novel form of the Gaddum equation.
    Ezechiáš M; Cajthaml T
    Toxicology; 2019 May; 420():21-28. PubMed ID: 30935971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.
    Cheng HC
    Pharmacol Res; 2004 Jul; 50(1):21-40. PubMed ID: 15082026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems associated with the application of the Cheng-Prusoff relationship to estimate atropine affinity constants using functional tissue responses.
    Eglen RM; Whiting RL
    Life Sci; 1989; 44(1):81-94. PubMed ID: 2913438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternative method to evaluate the nature of an antagonist and its potency: a theoretical approach.
    Calderone V
    J Pharmacol Toxicol Methods; 1998 Apr; 39(3):129-35. PubMed ID: 9741386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exact correction to the "Cheng-Prusoff" correction.
    Munson PJ; Rodbard D
    J Recept Res; 1988; 8(1-4):533-46. PubMed ID: 3385692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How we describe competitive antagonists: three questions of usage.
    Jenkinson DH
    Trends Pharmacol Sci; 1991 Feb; 12(2):53-4. PubMed ID: 2024288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing receptor affinity for inverse agonists: Schild and Cheng-Prusoff methods revisited.
    Giraldo J; Serra J; Roche D; Rovira X
    Curr Drug Targets; 2007 Jan; 8(1):197-202. PubMed ID: 17266542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental and theoretical comparisons between the classical Schild analysis and a new alternative method to evaluate the pA2 of competitive antagonists.
    Calderone V; Baragatti B; Breschi MC; Martinotti E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):477-87. PubMed ID: 10598787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Apparent Noncompetitive Responses to Competitive H(1)-Histamine Receptor Antagonists in Fluorescent Imaging Plate Reader-Based Calcium Assays.
    Miller TR; Witte DG; Ireland LM; Kang CH; Roch JM; Masters JN; Esbenshade TA; Hancock AA
    J Biomol Screen; 1999; 4(5):249-258. PubMed ID: 10838445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of competitive agonist-antagonist interactions by nonlinear regression.
    Lew MJ; Angus JA
    Trends Pharmacol Sci; 1995 Oct; 16(10):328-37. PubMed ID: 7491710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developments of computer-based estimation of pA2 values and associated analysis.
    Stone M; Angus JA
    J Pharmacol Exp Ther; 1978 Dec; 207(3):705-18. PubMed ID: 731426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions.
    Pöch G; Brunner F; Kühberger E
    Br J Pharmacol; 1992 Jul; 106(3):710-6. PubMed ID: 1504755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Schild regression in the process of receptor classification.
    Kenakin TP
    Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology.
    Belz GG
    Br J Clin Pharmacol; 2003 Jul; 56(1):3-10. PubMed ID: 12848769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell recombinant pharmacology: bovine alpha(1a)-adrenoceptors in rat-1 fibroblasts release intracellular ca(2+), display subtype-characteristic agonism and antagonism, and exhibit an antagonist-reversible inverse concentration-response phase.
    Pediani JD; MacKenzie JF; Heeley RP; Daly CJ; McGrath JC
    J Pharmacol Exp Ther; 2000 Jun; 293(3):887-95. PubMed ID: 10869389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.